BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 2456145)

  • 1. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
    Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
    Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
    Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
    Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody against human ovarian tumor-associated antigens.
    Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
    J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
    Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
    Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical demonstration of HNK-1-defined antigen in gynecologic tumors with argyrophilia.
    Ueda G; Yamasaki M; Inoue M; Tanaka Y; Inoue Y; Abe Y; Tanizawa O
    Int J Gynecol Pathol; 1986; 5(2):143-50. PubMed ID: 2424852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas.
    Sonoda K; Nakashima M; Kaku T; Kamura T; Nakano H; Watanabe T
    Cancer; 1996 Apr; 77(8):1501-9. PubMed ID: 8608535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
    Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
    J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
    Berezowski K; Stastny JF; Kornstein MJ
    Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
    Friedman EL; Hayes DF; Kufe DW
    Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the specificity by immunohistology of a monoclonal antibody to a novel epithelial antigen of ovarian carcinomas.
    Mariani-Costantini R; Agresti R; Colnaghi MI; Ménard S; Andreola S; Rilke F
    Pathol Res Pract; 1985 Aug; 180(2):169-80. PubMed ID: 3903701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-H4 overexpression in ovarian tumors.
    Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
    Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
    Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
    Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New monoclonal antibodies against colon cancer-associated antigens.
    Drewinko B; Yang LY; Chan J; Trujillo JM
    Cancer Res; 1986 Oct; 46(10):5137-43. PubMed ID: 2428473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of monoclonal antibodies using spleen cells from nude mice bearing human tumors.
    Al Saati T; Blancher A; Calvas P; Neulat-Duga I; Delsol G
    Ann Pathol; 1987; 7(1):1-8. PubMed ID: 3040026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.
    Garin-Chesa P; Campbell I; Saigo PE; Lewis JL; Old LJ; Rettig WJ
    Am J Pathol; 1993 Feb; 142(2):557-67. PubMed ID: 8434649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoperoxidase localization of a high-molecular-weight mucin recognized by monoclonal antibody 1D3.
    Gangopadhyay A; Bhattacharya M; Chatterjee SK; Barlow JJ; Tsukada Y
    Cancer Res; 1985 Apr; 45(4):1744-52. PubMed ID: 3884144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.